Fagron

Fagron is a multinational pharmaceutical entity founded in 1990, specializing in the development, production, and distribution of pharmaceutical compounding solutions. The company provides customized medication, active pharmaceutical ingredients, and specialized equipment to hospitals, clinics, and compounding pharmacies globally. Operating as a B2B and B2C provider, Fagron maintains a robust presence in the personalized medicine sector, ensuring healthcare providers have access to high-quality, tailored therapeutic options.

With a workforce of 1,000-5,000 employees, Fagron manages operations across 8 global locations. The company’s infrastructure supports complex supply chains and regulatory compliance in the pharmaceutical industry. Meet Fagron's team to understand the organizational structure and leadership driving these operations. The firm’s technical focus includes the delivery of active pharmaceutical ingredients and specialized compounding services, which are essential for modern clinical environments requiring patient-specific medication formulations.

Publicly traded on European stock exchanges under the ticker EPA: FAGR, the company reports annual revenue of $1.1B. Fagron’s strategic focus on personalized medicine and pharmaceutical innovation allows it to address specific patient needs that mass-produced pharmaceuticals cannot satisfy. By leveraging its extensive network and technical expertise, the company continues to expand its footprint in the pharmaceutical compounding market, providing critical support to healthcare systems across Europe, North America, South America, Asia, and Africa.